Ph.D. Alan J. Main - 28 Feb 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
EVP, Innov & Chem Sciences
Signature
/s/ Alan J. Main, Ph.D.
Issuer symbol
LXRX
Transactions as of
28 Feb 2025
Net transactions value
-$29,101
Form type
4
Filing time
03 Mar 2025, 16:32:25 UTC
Previous filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +25,667 +10% 281,391 28 Feb 2025 Direct F1
transaction LXRX Common Stock Options Exercise +32,904 +12% 314,295 28 Feb 2025 Direct F1
transaction LXRX Common Stock Options Exercise +68,243 +22% 382,538 28 Feb 2025 Direct F1
transaction LXRX Common Stock Tax liability $29,101 -43,434 -11% $0.6700 339,104 28 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -25,667 -100% 0 28 Feb 2025 Common Stock 25,667 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -32,904 -50% 32,903 28 Feb 2025 Common Stock 32,904 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -68,243 -33% 136,487 28 Feb 2025 Common Stock 68,243 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.